Sector not mapped · coverage Oct 12, 2026–Oct 12, 2026
Estimated market comparison · not an official filing fact
Available with Pro
Average post-trade price move across enriched rows. It is historical, sample-limited, does not account for exact execution prices or portfolio weights, and is not evidence that the filing activity caused a market move.
Disclosure alert preview
Based on a real public filing
Lisa C. McClain
$1K - $15K
This watch matched after the disclosure became public. It is not a real-time trade signal. Source checked Oct 23, 2026.
Official filingThis page summarizes public STOCK Act disclosures involving IBRX. It is useful for seeing which lawmakers reported IBRX transactions, how many filings are visible, the buy/sell mix, and whether the newest public filing describes a recent or delayed trade.
Oct 12, 2026
Public House and Senate STOCK Act disclosures normalized by Congressional Trader.
Filing date can trail transaction date. This page is for research and monitoring, not investment advice.
Congressional Trader tracks 2 public STOCK Act disclosures for IBRXacross 1 lawmakers. This page separates purchases from sales, shows filing delays, and links each disclosure back to the individual politician profile when available.
The most recent IBRX filing shown here was filed on Oct 12, 2026 by Lisa C. McClain as a purchase. Related lawmakers include Lisa C. McClain.
Unlock 30/90-day post-trade summaries, committee overlap, and CSV-oriented research views for high-intent ticker research.
Compare Pro plansRecent IBRX disclosures include Lisa C. McClain.
The visible sample currently shows 2 purchases and 0 sales or partial sales.
No. This page summarizes public filings for research and monitoring. It is not investment advice.
